Published on October 31st, 20190
Ketterer Browne & Anderson
TINA.org obtained the letters through a Freedom of Information Act request. One of the firms was Ketterer Browne & Anderson.
Here’s what the Ketterer Browne & Anderson TV ad cited in the letter said:
Attention, people with diabetes. The FDA has just issued a warning that Invokana may cause an increased risk of amputations. If this has happened to you or a loved one, call right now.
And what the FTC said:
We note that the FDA has advised patients not to stop taking their diabetes medicine without first talking to their health care professional. Accordingly, the implication that FDA has warned patients to stop taking Invokana appears to be false. In addition, this ad may convey to a significant number of viewers that taking Invokana poses a substantial risk of amputations, and that the risk of taking it outweighs its benefits. Unless you have competent and reliable scientific evidence for such claims, you should not make them.
Find more of our coverage on pharmaceuticals here.